Deanna Koger

1.1k total citations
9 papers, 902 citations indexed

About

Deanna Koger is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Deanna Koger has authored 9 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Deanna Koger's work include Alzheimer's disease research and treatments (5 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). Deanna Koger is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). Deanna Koger collaborates with scholars based in United States and Russia. Deanna Koger's co-authors include Kelly R. Bales, Steven M. Paul, Suizhen Lin, Feng Liu, Seema Malkani, Milla Koistinaho, Jeffrey Hanson, Xin Wu, Michail A. Esterman and Richard E. Higgs and has published in prestigious journals such as Nature Medicine, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Deanna Koger

9 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deanna Koger United States 6 681 322 269 254 116 9 902
Shengjun Chang United States 6 590 0.9× 147 0.5× 376 1.4× 205 0.8× 133 1.1× 8 851
Nathalie Pierrot Belgium 21 881 1.3× 238 0.7× 641 2.4× 396 1.6× 217 1.9× 30 1.4k
Shabnam Baig United Kingdom 9 616 0.9× 183 0.6× 289 1.1× 194 0.8× 115 1.0× 11 922
Junxiang Yin United States 19 437 0.6× 504 1.6× 429 1.6× 267 1.1× 64 0.6× 38 1.3k
Amita Quadros United States 14 673 1.0× 403 1.3× 334 1.2× 150 0.6× 156 1.3× 18 1.1k
Dorothy R. Schuler United States 7 695 1.0× 248 0.8× 272 1.0× 364 1.4× 119 1.0× 8 1.0k
Kevin P. Koster United States 11 395 0.6× 182 0.6× 236 0.9× 135 0.5× 59 0.5× 17 697
Afshin Safavi United States 6 573 0.8× 137 0.4× 362 1.3× 165 0.6× 110 0.9× 9 837
Evelyn Nwabuisi‐Heath United States 6 489 0.7× 177 0.5× 196 0.7× 167 0.7× 92 0.8× 6 630
Jason J. Fritz United States 12 575 0.8× 149 0.5× 441 1.6× 241 0.9× 122 1.1× 14 883

Countries citing papers authored by Deanna Koger

Since Specialization
Citations

This map shows the geographic impact of Deanna Koger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deanna Koger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deanna Koger more than expected).

Fields of papers citing papers by Deanna Koger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deanna Koger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deanna Koger. The network helps show where Deanna Koger may publish in the future.

Co-authorship network of co-authors of Deanna Koger

This figure shows the co-authorship network connecting the top 25 collaborators of Deanna Koger. A scholar is included among the top collaborators of Deanna Koger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deanna Koger. Deanna Koger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Walgren, Jennie, et al.. (2014). Withdrawal Assessment Following Subchronic Oral Ketamine Administration in Cynomolgus macaques. Drug Development Research. 75(3). 162–171. 5 indexed citations
3.
Hunter, Jesse M., John R. Cirrito, Jessica L. Restivo, et al.. (2012). Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice. Brain Research. 1467. 120–132. 32 indexed citations
4.
Zhao, Lingzhi, Suizhen Lin, Kelly R. Bales, et al.. (2009). Macrophage-Mediated Degradation of β-Amyloid via an Apolipoprotein E Isoform-Dependent Mechanism. Journal of Neuroscience. 29(11). 3603–3612. 60 indexed citations
5.
Bales, Kelly R., Feng Liu, Su Wu, et al.. (2009). HumanAPOEIsoform-Dependent Effects on Brain β-Amyloid Levels in PDAPP Transgenic Mice. Journal of Neuroscience. 29(21). 6771–6779. 223 indexed citations
6.
Sullivan, Patrick M., Baoqin Han, Brian E. Mace, et al.. (2009). Reduced levels of human apoE4 protein in an animal model of cognitive impairment. Neurobiology of Aging. 32(5). 791–801. 101 indexed citations
7.
Takeuchi, Kumiko, Todd J. Kohn, Vincent P. Rocco, et al.. (2005). Advances toward new antidepressants beyond SSRIs: 1-Aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 5. Bioorganic & Medicinal Chemistry Letters. 16(9). 2347–2351. 17 indexed citations
8.
Koistinaho, Milla, Suizhen Lin, Xin Wu, et al.. (2004). Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides. Nature Medicine. 10(7). 719–726. 462 indexed citations
9.
Bales, Kelly R., Deanna Koger, Songgu Wu, et al.. (2004). P4-396 Administration of an anti-Aβ FAB fragment to APP V717F transgenic mice reduces neuritic plaque. Neurobiology of Aging. 25. S587–S587. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026